苯西酮 | 115-55-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻嗪类
• 中文名称: 苯西酮
• 中文别名: 苯噻酮
• 英文名称: 2-ethyl-2-phenyl-thiomorpholine-3,5-dione
• 英文别名: 2-Aethyl-2-phenyl-thiomorpholin-3,5-dion；2-Ethyl-2-phenyl-thiomorpholin-3,5-dion；Phenylthilone；2-ethyl-2-phenylthiomorpholine-3,5-dione
• CAS: 115-55-9
• 化学式: C₁₂H₁₃NO₂S
• 分子量: 235.307
• InChiKey: IJCATHLRDWDKAS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  71.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2934999090

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 生成 苯西酮
  参考文献：
  名称：

  2,2-Dialkyl-3,5-thiamorpholinediones

  摘要：

  DOI：

  10.1021/ja01639a051

文献信息

• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• USE OF OXYGEN ANTAGONISTS FOR EX VIVO PRESERVATION OF TISSUES OR ORGANS
  申请人：Fred Hutchinson Cancer Research Center

  公开号：EP2949212A1

  公开（公告）日：2015-12-02

  There is provided the use of oxygen antagonists for inducing stasis in cells, tissues and/or organs in vivo or in an organism overall. It includes methods and apparatuses for achieving stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia and cancer is provided.

  本发明提供了使用氧拮抗剂诱导体内或整个生物体内的细胞、组织和/或器官停滞的方法。它包括在任何这些生物材料中实现停滞的方法和装置，以便保存和/或保护它们。在具体的实施方案中，提供了用于器官移植、热疗、伤口愈合、失血性休克、旁路手术的心脏麻痹、神经变性、低体温和癌症的治疗方法和装置。
• Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
  申请人：Roth B. Mark

  公开号：US20050136125A1

  公开（公告）日：2005-06-23

  The present invention concerns the use of oxygen antagonists for inducing stasis in cells, tissues, and/or organs in vivo or in an organism overall. It includes methods and apparatuses for achieving stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer is provided.

  本发明涉及使用氧拮抗剂诱导体内或整个生物体内的细胞、组织和/或器官停滞。它包括在任何这些生物材料中实现停滞的方法和装置，以便保存和/或保护它们。在具体的实施方案中，提供了用于器官移植、热疗、伤口愈合、失血性休克、旁路手术的心脏麻痹、神经变性、低体温和癌症的治疗方法和装置。
• Methods, compositions and devices for inducing stasis in tissues and organs
  申请人：Roth B. Mark

  公开号：US20050147692A1

  公开（公告）日：2005-07-07

  The present invention concerns the use of oxygen antagonists for inducing stasis in tissue, including all or part of organs. It includes methods and apparatuses for achieving stasis in tissue, so as to preserve and/or protect them. In specific embodiments, preservation methods and apparatuses for preserving tissue for transplantation purposes is provided.

  本发明涉及使用氧拮抗剂诱导组织停滞，包括全部或部分器官。本发明包括实现组织停滞的方法和装置，以便保存和/或保护组织。在具体的实施方案中，本发明提供了为移植目的保存组织的保存方法和装置。
• Methods, compositions and devices for inducing stasis in cells
  申请人：Roth B. Mark

  公开号：US20050170019A1

  公开（公告）日：2005-08-04

  The present invention concerns the use of oxygen antagonists for inducing stasis in cells. It includes methods and apparatuses for achieving stasis in cells, so as to preserve and/or protect them. In specific embodiments, preservation methods and apparatuses for storing platelets is provided.

  本发明涉及使用氧拮抗剂诱导细胞停滞。它包括实现细胞停滞的方法和装置，以便保存和/或保护细胞。在具体的实施方案中，提供了用于储存血小板的保存方法和装置。